Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
about
Treatment of euvolemic hyponatremia in the intensive care unit by ureaVasopressin receptor antagonists and their role in clinical medicine.Vasopressin-receptor antagonists.Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure.The role of v2 receptor antagonists in the treatment of hyponatremia.Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
P2860
Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Evaluation and management of h ...... opressin receptor antagonists.
@ast
Evaluation and management of h ...... opressin receptor antagonists.
@en
type
label
Evaluation and management of h ...... opressin receptor antagonists.
@ast
Evaluation and management of h ...... opressin receptor antagonists.
@en
prefLabel
Evaluation and management of h ...... opressin receptor antagonists.
@ast
Evaluation and management of h ...... opressin receptor antagonists.
@en
P2093
P2860
P356
P1476
Evaluation and management of h ...... opressin receptor antagonists.
@en
P2093
Daniel Batlle
Nishant Jalandhara
Sheldon Chen
P2860
P356
10.1038/NCPNEPH0401
P577
2007-02-01T00:00:00Z